IntroductionSteroid hormones regulate cell proliferation, survival and development and have been involved in the origin and/or progression of cancer [1][2][3][4][5][6]. In the last decades, many epidemiological and experimental studies have suggested that steroid hormones may be etiologic factors in tumor generation, but whereas for some tumors, the link between hormones and cancer is well established, in other cases the relationship is not fully defined or even contradictory [1,[7][8][9].Many human cancers, especially those of reproductive tissues, depend on progesterone (PG) [9]. PG is known to participate in the regulation of several physiological and pathological processes in mammals, such as ovarian function, growth and differentiation of the uterine endometrium and mammary gland [10]. However, PG also participates in non-reproductive processes, such as neural excitability, learning and memory, and in pathological processes like cancer [10][11][12]. In literature, however, data exploring the relationship between progesterone and cancer are controversial. One of the main problems lies in the fact that depending on the cell type, hormonal environment, growth conditions, and developmental stage, progesterone can either stimulate or inhibit cell proliferation or promote cell differentiation [13]. It has been reported that the lifetime exposure to reproductive hormones, in particular progesterone and/or estrogens, affects the risk of breast cancer and melanoma [12]. Melanoma is a widespread skin cancer with very poor prognosis. It is an old story, however still debated, that the outcome of established melanoma is influenced by endocrine status although the acquisition of melanoma does not seem to be influenced by female sex hormones [14,15]. Early studies showed that female patients with malignant melanoma had some survival advantage [16], which in some studies was observed in preas opposed to post-menopausal women [17][18][19]. Others larger multivariate analyses, however, demonstrated that it was equally strong in pre-as well as in post-menopausal groups [20]. Parallely, the literature concerning melanoma progression in pregnancy is also controversial [21][22][23][24], although several recent reports demonstrate that pregnancyassociated melanomas have poorer outcomes than other melanomas [25][26][27][28][29].In vitro progesterone influences melanoma growth [30][31][32][33], but several melanoma cell lines have been studied and very different experimental protocols have been used, so that the results actually available in literature are not univocal. Further research on this topic is thus needed, especially in view of the widespread use of PG in clinical practice. In this study, we report the results obtained by testing in vitro the effects of a wide range of concentrations of PG on the growth and viability of human melanoma cells.
Materials and methods
Cell Culture and TreatmentsThe human melanoma A-375 cell line was purchased from the American Type Culture Collection (ATCC, Rockville, MD) and grown in DMEM su...